Liminal BioSciences Inc(NASDAQ:LMNL) 
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on discovery, development, and commercialization of novel small molecule drug candidates for the treatment of patients suffering from respiratory fibrotic diseases and other fibrotic or inflammatory diseases that have high...
Website: http://www.liminalbiosciences.com
Founded: 1994
Full Time Employees: 300
CEO: Kenneth Harry Galbraith
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-03-29
P
O 3.74
H 3.79
L 3.53
C 3.53
V 2,766
10EMA 3.53
20EMA 3.53
60EMA 3.53
120EMA 3.53
250EMA 3.53